• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Evercore ISI and the Digital Therapeutics Alliance to Host Digital Health Leaders at HLTH 2024

    10/2/24 8:00:00 AM ET
    $EVR
    Investment Managers
    Finance
    Get the next $EVR alert in real time by email

    Evercore (NYSE:EVR), the Digital Therapeutics Alliance (DTA) and HLTH, a leading platform bringing together the health ecosystem, will co-host a dedicated program on digital health and digital therapeutics at HLTH 2024 in Las Vegas, Oct. 20-23. This program marks Evercore's sixth consecutive year hosting at HLTH and third year collaborating with thought leaders from DTA.

    The program, Tech Meets Therapy: Evaluating the Digital Health Landscape, is scheduled for Monday, Oct. 21, 8-9 a.m. PST at the Venetian Expo Center in Las Vegas. Two panels of leading industry executives will focus on the current investment environment within digital health as well as opportunities and insights to establish strategic partnerships.

    "The digital health and digital therapeutics sectors continue to evolve and adapt in a rapidly changing market, highlighting the resilience of still-promising verticals within healthcare. Our panels will delve into prevailing sector trends as they relate to investment outlooks and the opportunities for establishing strategic partnerships to deliver clinical and economic value," said Elizabeth Anderson, Evercore ISI's Healthcare Technology & Distribution analyst. "We are excited to continue our partnership with both HLTH and DTA this year to share our combined insights on the evolving landscape."

    Jessica Hauflaire, COO of DTA, said, "The investment landscape plays a critical role in the advancement of digital health technologies in healthcare. We thank Evercore for bringing us together to discuss the adoption of digital health and how investors can influence the next wave of healthcare transformation."

    "Given the rapid evolution of the digital therapeutics landscape in the past year, having well-informed funding and reimbursement strategies is more crucial than ever," said Rich Scarfo, president of HLTH. "Our ongoing collaboration with Evercore and the Digital Therapeutics Alliance equips HLTH attendees with the expert insights and guidance needed to navigate these shifts and seize new opportunities for innovation."

    For more information, visit www.hlth.com/2024event/partner-programs/digital-therapeutics-alliance.

    About Evercore

    Evercore (NYSE:EVR) is a premier global independent investment banking advisory firm. We are dedicated to helping our clients achieve superior results through trusted independent and innovative advice on matters of strategic and financial significance to boards of directors, management teams and shareholders, including mergers and acquisitions, strategic shareholder advisory, restructurings and capital structure. Evercore also assists clients in raising public and private capital, delivers equity research and equity sales and agency trading execution, and provides wealth and investment management services to high-net-worth and institutional investors. Founded in 1995, the firm is headquartered in New York and maintains offices and affiliate offices in major financial centers in the Americas, Europe, the Middle East and Asia. For more information, please visit www.evercore.com.

    About HLTH

    HLTH (pronounced "health") is the leading platform bringing together the entire health ecosystem, focused on health innovation and transformation. From unparalleled events with industry-leading speakers to inspirational digital content and mission-driven initiatives, HLTH creates a unique marketplace for the health community leading the dialogue and development of a new health ecosystem.

    About Digital Therapeutics Alliance (DTA)

    As the leading global authority on the evolution of digital health technology, Digital Therapeutics Alliance (DTA) is a 501(c)(6) non-profit trade association of industry leaders and stakeholders dedicated to the understanding, adoption, and integration of digital therapeutics into healthcare. DTA works to enable expanded access to high quality, evidence-based digital therapeutics for patients, clinicians, and payors to improve clinical and health economic outcomes. As the leading international organization on digital therapeutic thought leadership and education, DTA provides the digital health ecosystem with the necessary tools to define, evaluate, and utilize DTx products.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20241002791730/en/

    Get the next $EVR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $EVR

    DatePrice TargetRatingAnalyst
    1/26/2026$435.00Buy
    BofA Securities
    12/11/2025$340.00Neutral
    UBS
    12/8/2025$373.00Overweight → Equal-Weight
    Morgan Stanley
    10/9/2025$400.00Buy
    Deutsche Bank
    10/3/2025$358.00Market Perform
    BMO Capital Markets
    7/14/2025Mkt Outperform → Mkt Perform
    Citizens JMP
    6/23/2025$312.00Equal-Weight → Overweight
    Morgan Stanley
    4/8/2025$230.00Mkt Perform → Mkt Outperform
    Citizens JMP
    More analyst ratings

    $EVR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    David Ke Joins Evercore as Senior Managing Director in the Equity Capital Markets Group

    Evercore announced today that David Ke has joined the firm as a senior managing director in the equity capital markets group, focused on biotechnology. He will be based in New York. "We are excited to welcome David to Evercore," said Naveen Nataraj, co-head of U.S. investment banking. "Biotechnology remains one of the most dynamic sectors in equity capital markets, and David's experience and deep investor relationships enhance our capabilities as we continue to support innovative companies as they access capital." "David brings a strong track record and deep biotechnology expertise to Evercore," said Kristy Grippi, head of equity capital markets at Evercore. "His experience will further

    3/12/26 8:00:00 AM ET
    $EVR
    Investment Managers
    Finance

    Evercore Wealth Management Promotes Sean Brady to Partner

    Evercore Wealth Management today announced the promotion of Sean Brady to partner. Mr. Brady is a wealth & fiduciary advisor at Evercore Wealth Management and its affiliate, Evercore Trust Company. "Sean is an experienced and thoughtful advisor," said Chris Zander, CEO of Evercore Wealth Management and Evercore Trust Company. "He is a strong contributor to our firm, able to manage complex planning challenges while always putting our clients first and working well within our unique team structure." Mr. Brady works with senior executives, private equity principals and families, delivering integrated strategic wealth planning and fiduciary services. He joined Evercore in 2024 from Clarfeld

    3/4/26 8:00:00 AM ET
    $EVR
    Investment Managers
    Finance

    Ben Carpenter Joins Evercore as Senior Managing Director in the Healthcare Investment Banking Group

    Evercore announced today that Ben Carpenter has joined the firm as a senior managing director in the healthcare investment banking group, where he will focus on the biopharma sector. He will be based in San Francisco. "We are pleased to welcome Ben to Evercore," said Naveen Nataraj, co-head of U.S. investment banking. "His extensive healthcare experience will further strengthen our franchise as we continue to invest in and expand our healthcare advisory platform." "We are excited to have Ben join the firm," said Francois Maisonrouge, chairman of Evercore's global healthcare group. "Biopharma is one of the most dynamic areas in global healthcare. Continuing to deepen our presence in this

    3/2/26 8:00:00 AM ET
    $EVR
    Investment Managers
    Finance

    $EVR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    BofA Securities initiated coverage on Evercore with a new price target

    BofA Securities initiated coverage of Evercore with a rating of Buy and set a new price target of $435.00

    1/26/26 10:01:23 AM ET
    $EVR
    Investment Managers
    Finance

    UBS resumed coverage on Evercore with a new price target

    UBS resumed coverage of Evercore with a rating of Neutral and set a new price target of $340.00

    12/11/25 9:08:53 AM ET
    $EVR
    Investment Managers
    Finance

    Evercore downgraded by Morgan Stanley with a new price target

    Morgan Stanley downgraded Evercore from Overweight to Equal-Weight and set a new price target of $373.00

    12/8/25 8:21:30 AM ET
    $EVR
    Investment Managers
    Finance

    $EVR
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Evercore Inc.

    SCHEDULE 13G/A - Evercore Inc. (0001360901) (Subject)

    3/26/26 6:22:31 PM ET
    $EVR
    Investment Managers
    Finance

    SEC Form 10-K filed by Evercore Inc.

    10-K - Evercore Inc. (0001360901) (Filer)

    2/20/26 4:51:14 PM ET
    $EVR
    Investment Managers
    Finance

    Amendment: SEC Form SCHEDULE 13G/A filed by Evercore Inc.

    SCHEDULE 13G/A - Evercore Inc. (0001360901) (Subject)

    2/10/26 11:21:52 AM ET
    $EVR
    Investment Managers
    Finance

    $EVR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Williamson Sarah K bought $580,860 worth of Shares of Class A common stock (2,000 units at $290.43), increasing direct ownership by 18% to 13,345 units (SEC Form 4)

    4 - Evercore Inc. (0001360901) (Issuer)

    3/10/26 5:01:56 PM ET
    $EVR
    Investment Managers
    Finance

    $EVR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Varney Christine A

    3 - Evercore Inc. (0001360901) (Issuer)

    3/20/26 4:31:48 PM ET
    $EVR
    Investment Managers
    Finance

    Director Williamson Sarah K bought $580,860 worth of Shares of Class A common stock (2,000 units at $290.43), increasing direct ownership by 18% to 13,345 units (SEC Form 4)

    4 - Evercore Inc. (0001360901) (Issuer)

    3/10/26 5:01:56 PM ET
    $EVR
    Investment Managers
    Finance

    CEO/Chairman Weinberg John S was granted 31,528 units of Shares of Class A common stock, increasing direct ownership by 5% to 636,890 units (SEC Form 4)

    4 - Evercore Inc. (0001360901) (Issuer)

    2/23/26 4:30:32 PM ET
    $EVR
    Investment Managers
    Finance

    $EVR
    Financials

    Live finance-specific insights

    View All

    Evercore Reports Record Fourth Quarter and Full Year 2025 Revenues; Quarterly Dividend of $0.84 Per Share

    Evercore Inc. (NYSE:EVR):   Fourth Quarter Results   Full Year Results   U.S. GAAP   Adjusted   U.S. GAAP   Adjusted   Q4 2025 Q4 2024   Q4 2025 Q4 2024     2025     2024       2025     2024   Net Revenues ($ mm) $ 1,288.3   $ 975.3     $ 1,298.1   $ 980.5     $ 3,855.8   $ 2,979.6     $ 3,884.0   $ 3,002.6   Operating Income

    2/4/26 6:45:00 AM ET
    $EVR
    Investment Managers
    Finance

    Evercore to Announce Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call on February 4, 2026

    Evercore (NYSE:EVR) will release its fourth quarter and full year 2025 financial results on Wednesday, February 4, 2026 at 6:45 a.m. Eastern Time. Evercore will host a related conference call, accessible via telephone and webcast, beginning at 8:00 a.m. Eastern Time that same day. Evercore's Chairman and Chief Executive Officer, John S. Weinberg, and Chief Financial Officer, Tim LaLonde, will review the Firm's fourth quarter and full year 2025 financial results. Following the review, there will be a question and answer session. This conference call is expected to last approximately one hour. Investors and analysts may participate in the live conference call by dialing (800) 245-3047 (to

    1/21/26 8:00:00 AM ET
    $EVR
    Investment Managers
    Finance

    Evercore Reports Third Quarter 2025 Results; Quarterly Dividend of $0.84 Per Share

    Evercore Inc. (NYSE:EVR):   Third Quarter Results   Year to Date Results   U.S. GAAP   Adjusted   U.S. GAAP   Adjusted   Q3 2025 Q3 2024   Q3 2025 Q3 2024   YTD 2025 YTD 2024   YTD 2025 YTD 2024 Net Revenues ($ mm) $ 1,038.9   $ 734.2     $ 1,047.1   $ 739.5     $ 2,567.5   $ 2,004.3     $ 2,585.8   $ 2,022.1   Operating Income ($ mm) $ 216.2   $

    10/29/25 6:45:00 AM ET
    $EVR
    Investment Managers
    Finance

    $EVR
    Leadership Updates

    Live Leadership Updates

    View All

    David Ke Joins Evercore as Senior Managing Director in the Equity Capital Markets Group

    Evercore announced today that David Ke has joined the firm as a senior managing director in the equity capital markets group, focused on biotechnology. He will be based in New York. "We are excited to welcome David to Evercore," said Naveen Nataraj, co-head of U.S. investment banking. "Biotechnology remains one of the most dynamic sectors in equity capital markets, and David's experience and deep investor relationships enhance our capabilities as we continue to support innovative companies as they access capital." "David brings a strong track record and deep biotechnology expertise to Evercore," said Kristy Grippi, head of equity capital markets at Evercore. "His experience will further

    3/12/26 8:00:00 AM ET
    $EVR
    Investment Managers
    Finance

    Ben Carpenter Joins Evercore as Senior Managing Director in the Healthcare Investment Banking Group

    Evercore announced today that Ben Carpenter has joined the firm as a senior managing director in the healthcare investment banking group, where he will focus on the biopharma sector. He will be based in San Francisco. "We are pleased to welcome Ben to Evercore," said Naveen Nataraj, co-head of U.S. investment banking. "His extensive healthcare experience will further strengthen our franchise as we continue to invest in and expand our healthcare advisory platform." "We are excited to have Ben join the firm," said Francois Maisonrouge, chairman of Evercore's global healthcare group. "Biopharma is one of the most dynamic areas in global healthcare. Continuing to deepen our presence in this

    3/2/26 8:00:00 AM ET
    $EVR
    Investment Managers
    Finance

    Ben Hart Joins Evercore as Senior Managing Director and Head of Asia Private Capital Advisory

    Evercore (NYSE:EVR) announced today that Ben Hart has joined the firm as a senior managing director and head of its Asia Private Capital Advisory (PCA) division. Based in Singapore, Mr. Hart will oversee Evercore PCA's activities across the Asia-Pacific region and work closely with the global PCA team to further expand the firm's secondaries advisory and broader private markets capabilities in the region. "We are thrilled to welcome Ben to Evercore," said Nigel Dawn, global head of Evercore's PCA division. "Ben has built an exceptional reputation and deep relationships across Asia's private markets ecosystem. His extensive experience in capital formation and distribution across APAC will

    2/23/26 8:00:00 AM ET
    $EVR
    Investment Managers
    Finance

    $EVR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Evercore Inc.

    SC 13G/A - Evercore Inc. (0001360901) (Subject)

    10/4/24 2:32:45 PM ET
    $EVR
    Investment Managers
    Finance

    SEC Form SC 13G/A filed by Evercore Inc. (Amendment)

    SC 13G/A - Evercore Inc. (0001360901) (Subject)

    2/13/24 5:04:33 PM ET
    $EVR
    Investment Managers
    Finance

    SEC Form SC 13G/A filed by Evercore Inc. (Amendment)

    SC 13G/A - Evercore Inc. (0001360901) (Subject)

    7/10/23 10:41:25 AM ET
    $EVR
    Investment Managers
    Finance